Correlation Between Aclaris Therapeutics and Qiagen NV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aclaris Therapeutics and Qiagen NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aclaris Therapeutics and Qiagen NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aclaris Therapeutics and Qiagen NV, you can compare the effects of market volatilities on Aclaris Therapeutics and Qiagen NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aclaris Therapeutics with a short position of Qiagen NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aclaris Therapeutics and Qiagen NV.

Diversification Opportunities for Aclaris Therapeutics and Qiagen NV

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aclaris and Qiagen is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and Qiagen NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qiagen NV and Aclaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aclaris Therapeutics are associated (or correlated) with Qiagen NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qiagen NV has no effect on the direction of Aclaris Therapeutics i.e., Aclaris Therapeutics and Qiagen NV go up and down completely randomly.

Pair Corralation between Aclaris Therapeutics and Qiagen NV

Given the investment horizon of 90 days Aclaris Therapeutics is expected to generate 5.58 times more return on investment than Qiagen NV. However, Aclaris Therapeutics is 5.58 times more volatile than Qiagen NV. It trades about 0.02 of its potential returns per unit of risk. Qiagen NV is currently generating about -0.01 per unit of risk. If you would invest  1,592  in Aclaris Therapeutics on August 27, 2024 and sell it today you would lose (1,212) from holding Aclaris Therapeutics or give up 76.13% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Aclaris Therapeutics  vs.  Qiagen NV

 Performance 
       Timeline  
Aclaris Therapeutics 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Aclaris Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Aclaris Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Qiagen NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qiagen NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Aclaris Therapeutics and Qiagen NV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aclaris Therapeutics and Qiagen NV

The main advantage of trading using opposite Aclaris Therapeutics and Qiagen NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aclaris Therapeutics position performs unexpectedly, Qiagen NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will offset losses from the drop in Qiagen NV's long position.
The idea behind Aclaris Therapeutics and Qiagen NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio